BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38529392)

  • 41. Effectiveness and safety of thromboprophylaxis with enoxaparin for prevention of pregnancy-associated venous thromboembolism.
    Cox S; Eslick R; McLintock C
    J Thromb Haemost; 2019 Jul; 17(7):1160-1170. PubMed ID: 31013386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
    Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
    J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How I approach the prevention and treatment of thrombotic complications in hospitalized patients.
    Akpan IJ; Hunt BJ
    Blood; 2023 Aug; 142(9):769-776. PubMed ID: 37339577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk assessment of venous thromboembolism and bleeding in COVID-19 patients.
    Wang L; Zhao L; Li F; Liu J; Zhang L; Li Q; Gu J; Liang S; Zhao Q; Liu J; Xu JF
    Clin Respir J; 2022 Mar; 16(3):182-189. PubMed ID: 35060325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD004318. PubMed ID: 30916777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD004318. PubMed ID: 30481366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A risk score for the management of pregnant women with increased risk of venous thromboembolism: a multicentre prospective study.
    Dargaud Y; Rugeri L; Vergnes MC; Arnuti B; Miranda P; Negrier C; Bestion A; Desmurs-Clavel H; Ninet J; Gaucherand P; Rudigoz RC; Berland M; Champion F; Trzeciak MC
    Br J Haematol; 2009 Jun; 145(6):825-35. PubMed ID: 19388925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports.
    Kyriakoulis KG; Kollias A; Kyriakoulis IG; Kyprianou IA; Papachrysostomou C; Makaronis P; Kotronias RA; Terentes-Printzios D; Toskas I; Mikhailidis DP
    Curr Vasc Pharmacol; 2022; 20(1):96-110. PubMed ID: 34431465
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence.
    Jiménez-Fonseca P; Gallardo E; Arranz Arija F; Blanco JM; Callejo A; Lavin DC; Costa Rivas M; Mosquera J; Rodrigo A; Sánchez Morillas R; Vares Gonzaléz M; Muñoz A; Carmona-Bayonas A
    Eur J Intern Med; 2022 Jun; 100():33-45. PubMed ID: 35227541
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Otten HM; Rutjes AW
    Cochrane Database Syst Rev; 2014 Aug; (8):CD008500. PubMed ID: 25171736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
    Felder S; Rasmussen MS; King R; Sklow B; Kwaan M; Madoff R; Jensen C
    Cochrane Database Syst Rev; 2019 Aug; 8(8):CD004318. PubMed ID: 31449321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
    Bauersachs RM; Dudenhausen J; Faridi A; Fischer T; Fung S; Geisen U; Harenberg J; Herchenhan E; Keller F; Kemkes-Matthes B; Schinzel H; Spannagl M; Thaler CJ;
    Thromb Haemost; 2007 Dec; 98(6):1237-45. PubMed ID: 18064320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregnancy after Combined Oral Contraceptive-Associated Venous Thromboembolism: An International Retrospective Study of Outcomes.
    Gris JC; Bourguignon C; Bouvier S; Nouvellon E; Laurent J; Perez-Martin A; Mousty E; Nikolaeva M; Khizroeva J; Bitsadze V; Makatsariya A
    Thromb Haemost; 2022 Oct; 122(10):1779-1793. PubMed ID: 35472708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis.
    Wiegers HMG; Schaafsma M; Guman NAM; Zelisse HS; Mulder FI; Middeldorp S; van Es N; Mom CH
    J Thromb Haemost; 2023 Feb; 21(2):294-302. PubMed ID: 36700503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preventing postsurgical venous thromboembolism: pharmacological approaches.
    Tufano A; Coppola A; Cerbone AM; Ruosi C; Franchini M
    Semin Thromb Hemost; 2011 Apr; 37(3):252-66. PubMed ID: 21455859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Venous thromboembolism prophylaxis in patients hospitalized in medical wards: A real life experience.
    Mahlab-Guri K; Otman MS; Replianski N; Rosenberg-Bezalel S; Rabinovich I; Sthoeger Z
    Medicine (Baltimore); 2020 Feb; 99(7):e19127. PubMed ID: 32049830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction and Prevention of Cancer-Associated Thromboembolism.
    Khorana AA; DeSancho MT; Liebman H; Rosovsky R; Connors JM; Zwicker J
    Oncologist; 2021 Jan; 26(1):e2-e7. PubMed ID: 33274815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis.
    Chi G; Goldhaber SZ; Kittelson JM; Turpie AGG; Hernandez AF; Hull RD; Gold A; Curnutte JT; Cohen AT; Harrington RA; Gibson CM
    J Thromb Haemost; 2017 Oct; 15(10):1913-1922. PubMed ID: 28762617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.